Company intelligence / Profile preview

Mile High Ophthalmics

Aurora, Colorado, United States

Ownership: Private
Development stage: Other

Overview

Mile High Ophthalmics developed and commercialized the VERUS Capsulorhexis Device, which was launched in February 2015. The device creates a round, centered capsulorhexis during cataract surgery, improving surgical outcomes and safety. Clinical feedback indicates the device adds less than 30 seconds to procedure time while ensuring consistent, reproducible results.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

University of Colorado School of Medicine at the Anschutz Medical Campus (licensing agreement for VERUS technology)Kaman Ventures, Inc. (Mile High Ophthalmics was the first portfolio company)

Beyond the preview

Go deeper on Mile High Ophthalmics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mile High Ophthalmics.

Explore the full profile